Valvular Heart Disease Clinical Trials

11 recruiting

Frequently Asked Questions

Common questions about Valvular Heart Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Prospective Evaluation of AI-ECG for SHD Detection

Heart Failure With Preserved Ejection Fraction (HFpEF; Diagnosis)Valvular Heart Disease Stenosis and Regurgitation (Diagnosis)Pulmonary Hypertension (Diagnosis)+1 more
Imperial College London590 enrolled5 locationsNCT07057466
Recruiting
Phase 2Phase 3

Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT)

Pulmonary HypertensionRheumatic Valvular Heart Disease
Sindh Institute of Cardiovascular Diseases100 enrolled1 locationNCT07462260
Recruiting
Not Applicable

Optimized Expansion of the Implanted Transcatheter Aortic Valve

Valvular Heart DiseaseAortic Stenosis Disease
Ole De Backer620 enrolled10 locationsNCT07042529
Recruiting

In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm

Heart FailureValvular Heart DiseaseMitral Regurgitation
Inova Health Care Services50 enrolled1 locationNCT06675448
Recruiting

Mechanism and Effect of Novel Metabolites on Valvular Heart Disease

Valvular Heart Disease
Sun Yat-sen University4,000 enrolled1 locationNCT07065500
Recruiting

Vibrometer Based Pulse Wave Analysis for Arterial Stiffness and Ischemic Heart Disease Risk Assessment

Heart FailureHypertensionDiabetes+2 more
HJN Sverige AB/Neko Health8,000 enrolled3 locationsNCT06984211
Recruiting

Development of CIRC Technologies

Heart FailureCardiovascular DiseasesAtrial Fibrillation+7 more
The Cleveland Clinic1,000 enrolled1 locationNCT05654272
Recruiting

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Heart FailureCardiotoxicityMyocardial Infarction+12 more
Peerbridge Health, Inc1,500 enrolled8 locationsNCT06699056
Recruiting
Not Applicable

Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population

Heart FailureValvular Heart DiseaseMitral Regurgitation
LMU Klinikum180 enrolled1 locationNCT06634121
Recruiting

Novel Echocardiographic Biomarkers Assessing the Myocardial Work in Heart Failure

Heart FailureCardiovascular DiseasesValvular Heart Disease+1 more
Aristotle University Of Thessaloniki300 enrolled1 locationNCT05573997
Recruiting

European Registry of Transcatheter Repair for Tricuspid Regurgitation

Heart FailureTricuspid RegurgitationValvular Heart Disease
LMU Klinikum3,000 enrolled1 locationNCT06307262
Recruiting

Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging

Heart FailureHypertrophic CardiomyopathyCoronary Artery Disease+4 more
Fatebenefratelli Hospital10,000 enrolled1 locationNCT05081115
Recruiting

Simultaneous Cardiac Surgery and Micronet-covered Stent Carotid Revascularization in High Perioperative Stroke Risk Patients

Myocardial InfarctionCoronary Artery DiseaseValvular Heart Disease+2 more
John Paul II Hospital, Krakow50 enrolled1 locationNCT04973579